Abstract
This manuscript explores the safety and potential efficacy of glucosodiene, an isomeric alkaline glucose compound, as a therapeutic agent for cancer treatment. The study focuses on conducting safety tests using BJ1 cells (Normal Skin Fibroblasts) and evaluates the cytotoxic effects of glucosodiene on these cells. The results indicate that glucosodiene, at a concentration of 100 ppm, does not exhibit toxicity or impair normal cellular functions. These findings suggest that the compound may selectively target tumor cells without affecting healthy cells. However, further research is needed to understand the mechanisms of action and confirm its efficacy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
